Cargando…

Fertility and Obstetric Outcomes of Assisted Reproductive Technology (ART) in Women With Adenomyosis Following Gonadotropin-Releasing Hormone Agonist Therapy: A Single-Center Experience

Introduction: Adenomyosis is an ambiguous disorder causing a wide variety of implications from dysmenorrhea, heavy menstrual bleeding, and infertility to pregnancy complications. Adenomyosis is associated with altered endocrine and inflammatory milieu, resulting in impaired implantation and reduced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Asha R, Duraikannan, Uthra Priyadarshini, Rao, Damodar R, Giridhar, Padmashri, Chinnasamy, Sivakumar N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552683/ https://www.ncbi.nlm.nih.gov/pubmed/37809195 http://dx.doi.org/10.7759/cureus.44691

Ejemplares similares

Pregnancy outcome with coexisting mole after intracytoplasmic sperm injection: A case series
por: Rao, Asha R., et al.
Publicado: (2015)

Female Papillary Thyroid Cancer Survivors Are at Increased Risk of Adenomyosis and Endometrial Hyperplasia
por: Tatarchuk, Tetiana, et al.
Publicado: (2023)

Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins
por: Sahib, Bahaa O, et al.
Publicado: (2023)

Leydig Cell Tumor-Induced Gonadotropin-Independent Precocious Puberty Progressing to Gonadotropin-Dependent Precocious Puberty Post Orchiectomy: Out of the Frying Pan Into the Fire
por: Singhania, Pankaj, et al.
Publicado: (2022)

The Safety of Human Chorionic Gonadotropin Monotherapy Among Men With Previous Exogenous Testosterone Use
por: Rainer, Quinn, et al.
Publicado: (2022)

Association Between Diabetes and Immunoglobulin M Antibodies Against Endogenous Gonadotropin-Releasing Hormone in Serum: A Meta-Analysis
por: Rakab, Amine, et al.
Publicado: (2022)

Luteinizing Hormone/Human Chorionic Gonadotropin Receptor N312S Single-Nucleotide Polymorphism and Its Impact on Clinical and Reproductive Outcomes in Assisted Reproductive Technology: A Prospective Cohort Study
por: Nagulapalli, Amulya, et al.
Publicado: (2023)

SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes Mellitus
por: Fazeli, Sasan, et al.
Publicado: (2019)

Fertility and Pregnancy Outcomes in Patients With Adenomyosis: Is Adenomyosis Synonymous With Infertility?
por: Calero, Maria Jose, et al.
Publicado: (2022)

The role of gonadotropin-releasing hormone agonists in female fertility preservation
por: Lee, Jae Hoon, et al.
Publicado: (2021)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021)

The Impact of Adenomyosis on Women's Fertility
por: Harada, Tasuku, et al.
Publicado: (2016)

Effect of Tamoxifen on the Management of Dopamine Agonist-Resistant Prolactinomas: A Systematic Review
por: Bazuhair, Tuqa, et al.
Publicado: (2023)

Relationship of Serum Leptin and Reproductive Hormones in Unexplained Infertile and Fertile Females
por: Baig, Mukhtiar, et al.
Publicado: (2019)

FRI657 Case Series On GLP-1 Receptor Agonist Related Acute Pancreatitis
por: Kumar Kulkarni, Abhigna Uday, et al.
Publicado: (2023)

SAT063 Dopaminergic Agonist Cabergoline Inhibits Autophagic Flux In Beta Pancreatic Cells
por: Francisco Mendez, Luis, et al.
Publicado: (2023)

THU334 Trends In GLP-1 Agonist Utilization In Diabetics With And Without Vascular Disease
por: Sargin, Pinar, et al.
Publicado: (2023)

Prevalence of Thyroid Autoimmune Antibodies in Women Seeking Fertility Care in Damascus, Syria
por: Aljarad, Mohammad, et al.
Publicado: (2019)

Comprehensive analysis of PPARγ agonist activities of stereo-, regio-, and enantio-isomers of hydroxyoctadecadienoic acids
por: Umeno, Aya, et al.
Publicado: (2020)

RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors
por: Chichura, Kylie, et al.
Publicado: (2022)

FRI652 Type 2 Diabetes Management: More GLP1 Agonists And Less Metformin?
por: Lopez Maldonado, Francisco J, et al.
Publicado: (2023)

Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment
por: Park, Chan Woo, et al.
Publicado: (2016)

ODP259 Evaluating the Efficacy and Safety of Long-Acting GLP-1 Receptor Agonist in T1DM Patients
por: Mohandas, Deene, et al.
Publicado: (2022)

Therapeutic Implications of Altered Energy Metabolism in Migraine: A State-of-the-Art Review
por: Hassan, Syed Adeel, et al.
Publicado: (2020)

SAT079 A Novel Variant In The Carboxyl Ester Lipase (CEL) Gene Causing MODY
por: Medavarapu, chalapathi Rao, et al.
Publicado: (2023)

Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article
por: Ghazanfar, Haider, et al.
Publicado: (2021)

RF28 | PSUN182 Risk of Pancreatitis After Glp-1 Receptor Agonist in Individuals With Known History of Pancreatitis
por: Kodali, Alimitha M, et al.
Publicado: (2022)

SAT085 Oral Glucagon-like Peptide-1 Receptor Agonist As Adjuvant Treatment In HNF1A-MODY
por: Tyler Broome, David
Publicado: (2023)

Adenomyosis and its impact on women fertility
por: Garavaglia, Elisabetta, et al.
Publicado: (2015)

Impact of adenomyosis on the outcome of in vitro fertilization
por: Qin, Yaoqin, et al.
Publicado: (2023)

Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series
por: Rojas Ortiz, Valentina, et al.
Publicado: (2021)

PSUN172 Prescribing SGLT-2 Inhibitors and GLP-1 Agonists in Primary Care: Improving Rates of Guideline-Concordant Practice
por: Schuetz, Samantha, et al.
Publicado: (2022)

Role of Glucagon-Like Peptide-1 Receptor Agonists on the Weight Loss of Individuals With Type 2 Diabetes: A Systematic Review
por: Irfan, Huma, et al.
Publicado: (2023)

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

SAT073 β Cell FFA2 Deficiency Suppresses Multiple Low Dose Streptozotocin (MLDS) Induced Diabetes
por: Xu, Kai, et al.
Publicado: (2023)

PSUN143 Perspectives of Patients Attending Endocrinology Clinic About COVID-19 Vaccination.
por: Mikkilineni, Pushyami, et al.
Publicado: (2022)

PSUN192 Therapeutic Benefit of GLP-1 Agonists in Patients with Type 1 Diabetes on Insulin Therapy: an Updated Systematic Review and Meta-analysis
por: Park, Jeayoung, et al.
Publicado: (2022)

PSUN188 Evaluating Response to GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Managed at a Veterans Affairs Hospital
por: Davis, Clifton, et al.
Publicado: (2022)

PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
por: Ferrara-Cook, Christine, et al.
Publicado: (2022)

Weight Loss of Over 100 lbs in a Patient of Prader-Willi Syndrome Treated With Glucagon-Like Peptide-1 (GLP-1) Agonists
por: Ahmed, Sana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gnjllb8a8umrvviesstjldrmop